Fremanezumab: First Global Approval

Hoy, SM

Hoy, SM (reprint author), Springer, Private Bag 65901, Auckland 0754, New Zealand.

DRUGS, 2018; 78 (17): 1829

Abstract

Fremanezumab-vfrm (hereafter referred to as fremanezumab) [AJOVY (TM)] is a fully humanized monoclonal antibody (IgG2 Delta a) developed by Teva Pharm......

Full Text Link